Healthcare Services US

US Longevity Clinics Market Analysis, 2024–2034

US Longevity Clinics Market Industry Trends and Forecast to 2034: Segmented by (Service, Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $3.57 Bn Estimated value
Estimate 2025 $3.88 Bn 39.4% of the global market
Projected 2034 $8.29 Bn 113.6% Adds $4.41 Bn over 9 forecast years
CAGR 2025–2034 8.8% Faster than 65% of 107 Healthcare Services markets here
Key players 5 Companies profiled
  • US is 39.38% of the global market.
  • In North America, the largest is US (this report) at $3.88 Bn.
  • Fastest growing: Canada at 10.9% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.41 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Longevity Clinics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $3.57 Bn — —
2025 (base) $3.88 Bn +$313.9 Mn —
2026 (forecast) $4.22 Bn +$341.6 Mn +8.8%
2027 (forecast) $4.59 Bn +$371.6 Mn +18.4%
2028 (forecast) $5.00 Bn +$404.3 Mn +28.8%
2029 (forecast) $5.44 Bn +$439.9 Mn +40.1%
2030 (forecast) $5.92 Bn +$478.6 Mn +52.5%
2031 (forecast) $6.44 Bn +$520.7 Mn +65.9%
2032 (forecast) $7.00 Bn +$566.6 Mn +80.5%
2033 (forecast) $7.62 Bn +$616.4 Mn +96.4%
2034 (forecast) $8.29 Bn +$670.7 Mn +113.6%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $9.86 Bn
  2. North America $4.22 Bn
  3. US (this report) $3.88 Bn
  4. APAC $2.33 Bn
  5. Europe $1.67 Bn
  6. China $789.9 Mn
  7. Canada $750.2 Mn
  8. Japan $615.3 Mn
  9. Middle East $430.8 Mn
  10. Latin America $422.1 Mn
  11. Germany $395.6 Mn
  12. UK $277.8 Mn
  13. France $266.8 Mn
  14. Italy $257.6 Mn
  15. Brazil $238.1 Mn
  16. Ecuador $218.2 Mn
  17. Spain $209.7 Mn
  18. India $161.4 Mn
  19. Saudi Arabia $147.6 Mn
  20. Africa $132.5 Mn
  21. Mexico $127.3 Mn
  22. Australia $123.9 Mn
  23. Russia $110.9 Mn
  24. New Zealand $96.9 Mn
  25. South Africa $59.5 Mn
  26. UAE $55.4 Mn
  27. Egypt $32.3 Mn
  28. Philippines $19.1 Mn
  29. Malaysia $17.2 Mn
  30. Hong Kong $14.8 Mn
  31. Thailand $13.5 Mn
  32. Singapore $10.2 Mn
  33. Kenya $7.6 Mn

The US Longevity Clinics Market Analysis Executive Summary

Longevity clinics offer check-ups, advanced tests and personal plans aimed at helping people live longer and stay healthy as they age.

Key segments of the longevity Clinics market include service (Advanced Diagnostics, Personalized Health Plans and IV and Regenerative Therapies) and model (Membership and Pay-per-Service).

US Longevity Clinics Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the longevity Clinics market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the longevity Clinics market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the longevity Clinics market.

Competitive Landscape for Longevity Clinics Market in US

The longevity Clinics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Longevity Clinics Market in US

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how longevity Clinics services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Longevity Clinics right now, from free public sources.

Clinical trials

25 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Longevity Metrics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 8 papers since 2021 (worldwide)

  1. An aging essential 8: closing the gap between geroscience and the public it serves. Biogerontology, 2026
  2. Biological Clocks: Ready for Prime Time? Journal of insurance medicine (New York, N.Y.), 2026
  3. Longevity clinics: between promise and peril. Aging, 2025
  4. Epigenetic Clocks and EpiScore for Preventive Medicine: Risk Stratification and Intervention Models for Age-Related Diseases. Journal of clinical medicine, 2025
  5. A Pragmatic Approach to Introducing Translational Geroscience Into the Clinic: A Paradigm Based on the Incremental Progression of Aging-Related Clinical Research. The journals of gerontology. Series A, Biological sciences and medical sciences, 2024
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Longevity Clinics in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Longevity Clinics are running in the US?
25 studies are recruiting, active or about to start in the US.[4]
How much research is published on Longevity Clinics?
PubMed lists 8 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Longevity Clinics in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Back to Catalogue
Keep exploring

Related Healthcare Services reports in US

See all
Same topic, other categories

Related on geriatric

See the topic